Free tool
Drug literature search
Last checked: Nov 20, 2026Source: PubMed, Europe PMC, OpenAlex
128 results in Europe PMC
PubMed plus preprints and full-text open access papers. Showing the first 25. Limited to clinical trials, meta-analyses and systematic reviews.
- Efficacy and safety of vosoritide in children with achondroplasia: a systematic review and meta-analysis.
Alfaraj GA, Alfaraj HA, Adel M, AlGadeeb RB. · Eur J Pediatr · 2026 · cited 1 timesmeta-analysis, systematic review
- Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia.
Savarirayan R, Hoover-Fong J, Irving M, Arundel P, de Bergua JM, Campeau PM, Candler T, Cocanougher BT, Cormier-Daire V, Edouard T, Fredwall SO, Harmatz P, Hoernschemeyer D, Irgens HU, Jamuar S, Kannu P, Legare JM, Leiva-Gea A, McDevitt H, Onesimo R, Phillips J, Del Pino M, Robinson ME, Rossi M, Skae M, Ward LM, White KK, Schmidt J, Lystig T, Salvatici A, Bai Y, Butler PW, van Veenhuyzen D, Rogoff D. · N Engl J Med · 2026 · cited 5 timesclinical trial, phase iii, multicenter study
- Navepegritide combined with lonapegsomatropin for the treatment of children with achondroplasia: 52-week results from the phase 2 COACH trial.
McDonnell CM, Irving M, Nolting LA, Abdelrahman SG, Dalby LW, Iklé JM, Jensen SM, Komirenko AS, Ominsky MS, Shu AD, Hove HB. · Eur J Endocrinol · 2026 · cited 1 timesclinical trial, phase ii, multicenter study
- Assessing signs and impacts of achondroplasia: psychometric evaluation of the Achondroplasia Child Experience Measures.
Brod M, McLeod L, Smith A. · J Patient Rep Outcomes · 2026 · cited 0 timesOpen accessclinical trial, phase ii, multicenter study
- Real-world outcomes of vosoritide in achondroplasia: A systematic review and meta-analysis of multinational clinical evidence.
Albuquerque ALB, Dacoregio MI, Rodrigues CG, Bertola DR, Zattar Ribeiro PV. · Genet Med · 2026 · cited 3 timesmeta-analysis, systematic review
- Efficacy and safety of Vosoritide in achondroplasia: A systematic review and meta-analysis.
Pahuja M, Prakash C, Umrao A, Chatterjee NS. · Indian J Med Res · 2026 · cited 0 timesOpen accessmeta-analysis, systematic review
- Efficacy and safety of limb lengthening in achondroplasia: A systematic review and meta-analysis.
Hosny G, AbdElnaser A, Elashhab A, Saad H. · Int Orthop · 2026 · cited 1 timesOpen accessmeta-analysis, research support, non-u.s. gov't
- A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.
Dauber A, Savarirayan R, Campeau PM, Carroll RS, Cheung M, Cormier-Daire V, de Bergua JM, Edouard T, Gonfiantini MV, Hoover-Fong J, Kannu P, Kinoshita Y, Kubota T, Mendoza-Londono R, Namba N, Ohata Y, Onesimo R, Palm K, Prada CE, Reynaud R, Rossi M, Semler O, Takasawa K, Bassi R, Ghani S, Huntsman Labed A, Osmond D, Sabir I, White J, Maghnie M. · NEJM Evid · 2026 · cited 0 timesclinical trial, phase iii, multicenter study
- Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial.
Savarirayan R, McDonnell C, Bacino CA, Hoernschemeyer DG, Legare JM, Abuzzahab MJ, Hofman PL, Campeau PM, de Bergua Domingo JM, Ward LM, Smit K, Smith A, Mao M, Ominsky MS, Freiberg LC, Shu AD, Hove HB. · JAMA Pediatr · 2026 · cited 12 timesOpen accessclinical trial, phase ii, multicenter study
- Cardiovascular risk in achondroplasia: a systematic review.
Lo I, Meti S, Mason A, McDevitt H, Constantinou P, Lucas-Herald AK. · J Med Genet · 2026 · cited 1 timessystematic review
- A phase II basket trial of vosoritide in children with RASopathies, ACAN, and NPR2 deficiency.
Dauber A, Zhang A, Shafaei N, Seaforth R, Pitner K, Dham N, Kanakatti Shankar R, Merchant N. · J Clin Endocrinol Metab · 2026 · cited 2 timesOpen accessclinical trial, phase ii
- Orthodontic and Maxillofacial Surgery Treatment in Achondroplasia for Orofacial Alterations: A Systematic Review and Preliminary Age-Stratified Guidelines.
Farronato M, Bedeschi MF, Grippaudo C, Tartaglia GM, Rinaldi B, Maspero C. · Orthod Craniofac Res · 2026 · cited 0 timesOpen accesssystematic review, review-article
- The association between disability and mortality among children and adolescents: A systematic review and meta-analysis.
Moyo-Chilufya M, Nguweneza A, Rotenberg S, Kuper H, Smythe T. · PLoS Med · 2026 · cited 1 timesOpen accessmeta-analysis, systematic review
- Efficacy and Safety of Oral Meclizine for Growth Promotion in Children with Achondroplasia: A Phase 2 Clinical Trial.
Matsushita M, Kitoh H, Kubota T, Okada K, Mishima K, Sawamura K, Kitaoka T, Fujiwara M, Kato Y, Amano Y, Nishida K, Imagama S. · Calcif Tissue Int · 2025 · cited 2 timesclinical trial, phase ii, research support, non-u.s. gov't
- Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study.
Savarirayan R, Irving M, Wilcox WR, Bacino CA, Hoover-Fong JE, Harmatz P, Polgreen LE, Palm K, Prada CE, Kubota T, Arundel P, Kotani Y, Leiva-Gea A, Bober MB, Hecht JT, Legare JM, Lawrinson S, Low A, Sabir I, Huntsman-Labed A, Day JRS. · Med · 2025 · cited 15 timesclinical trial, phase iii, research support, non-u.s. gov't
- Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life.
Savarirayan R, Irving M, Wilcox WR, Bacino CA, Hoover-Fong JE, Harmatz P, Polgreen LE, Mohnike K, Prada CE, Kubota T, Arundel P, Leiva-Gea A, Rowell R, Low A, Sabir I, Huntsman-Labed A, Day J. · Genet Med · 2024 · cited 15 timesresearch support, non-u.s. gov't, randomized controlled trial
- Oral Infigratinib Therapy in Children with Achondroplasia.
Savarirayan R, De Bergua JM, Arundel P, Salles JP, Saraff V, Delgado B, Leiva-Gea A, McDevitt H, Nicolino M, Rossi M, Salcedo M, Cormier-Daire V, Skae M, Kannu P, Phillips J, Saal H, Harmatz P, Candler T, Hill D, Muslimova E, Weng R, Bai Y, Raj S, Hoover-Fong J, Irving M, Rogoff D. · N Engl J Med · 2025 · cited 17 timesclinical trial, phase ii, multicenter study
- Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.
Savarirayan R, Wilcox WR, Harmatz P, Phillips J, Polgreen LE, Tofts L, Ozono K, Arundel P, Irving M, Bacino CA, Basel D, Bober MB, Charrow J, Mochizuki H, Kotani Y, Saal HM, Army C, Jeha G, Qi Y, Han L, Fisheleva E, Huntsman-Labed A, Day J. · Lancet Child Adolesc Health · 2024 · cited 59 timesclinical trial, phase ii, research support, non-u.s. gov't
- Prednisone, not vamorolone, suppresses novel serum bone and cartilage biomarkers associated with growth failure in children with Duchenne muscular dystrophy.
Tobin RA, Dang UJ, Hagerty L, Ward LM, Rooman R, Konopka KH, Clemens PR, Guglieri M, Damsker J, Ziemba M, Hathout Y, Hoffman EP. · Sci Rep · 2026 · cited 0 timesOpen accessresearch support, non-u.s. gov't, randomized controlled trial
- A comprehensive systematic review of health-related quality of life measures in short stature paediatric patients.
Adedeji A, Witt S, Innig F, Quitmann J. · Endocrine · 2024 · cited 6 timesOpen accesssystematic review
- Challenges to self-care and domestic life for adults with disproportionate short statured skeletal dysplasia: a mixed method systematic review.
Prescelia C, Ireland PJ, Blanco C, Nguyen D, Pacey V. · Disabil Rehabil · 2025 · cited 2 timessystematic review
- How pain affect real life of children and adults with achondroplasia: A systematic review.
Onesimo R, Sforza E, Bedeschi MF, Leoni C, Giorgio V, Rigante D, De Rose C, Kuczynska EM, Romeo DM, Palmacci O, Massimi L, Porro M, Gonfiantini MV, Selicorni A, Allegri A, Maghnie M, Zampino G. · Eur J Med Genet · 2023 · cited 11 timessystematic review
- Neurosurgical management of cervicomedullary compression, spinal stenosis, and hydrocephalus in pediatric achondroplasia: a systematic review.
Akinnusotu O, Isaacs AM, Stone M, Bonfield CM. · J Neurosurg Pediatr · 2023 · cited 12 timessystematic review
- Phase 2 Trial of Vosoritide Use in Patients with Hypochondroplasia: A Pharmacokinetic/Pharmacodynamic Analysis.
Galetaki D, Zhang A, Qi Y, Merchant N, Kanakatti Shankar R, Boucher K, Shafaei N, Seaforth R, Dham N, Dauber A. · Horm Res Paediatr · 2026 · cited 0 timesclinical trial, phase ii
- Incremental yield of prenatal exome sequencing in fetuses with skeletal system abnormalities: A systematic review and meta-analysis.
Wang Y, Lv Y, Yao J, Ding H, Li G, Li J, Chen L. · Acta Obstet Gynecol Scand · 2025 · cited 6 timesOpen accessmeta-analysis, systematic review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.